People living with HIV may also have to manage other health conditions like cardiovascular disease, type 2 diabetes, ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...

The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...

Young adults with type 2 diabetes and lower incomes face significantly higher mortality risks, highlighting socioeconomic ...

KEY BUSINESS HIGHLIGHTSPhase 2a clinical trial for Cholesterol Efflux Mediator™ VAR 200 in patients with diabetic kidney disease expected to ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA ...

In an interview with The News-Letter, its CEO, Johns Hopkins School of Medicine Class of 1999 alum Dr. David-Alexandre C ... ...

GLP-1RA drugs and SGLT2 inhibitors were associated with a lower risk for nonalcoholic fatty liver disease among individuals with type 2 diabetes.

Diabetes is very common in people living in post-acute and long-term environments, affecting 25% to 34% of these individuals.

U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and weight loss, according to a review of patient data published on Monday, the ...